The financials
Perrigo Company plc by the numbers
Perrigo Company plc (PRGO) reported revenue of $969M in Q1 2026 (quarter ended March 28, 2026), down 7.2% from the same quarter a year earlier. That came with a gross margin of 34% and net loss of $399M. For the full year FY2025, revenue was $4.25B (−2.8% year on year) and net income −$1.43B. Its largest product in 2026-Q2 was Upper Respiratory at $178M, 22% of the disclosed total, just ahead of Skin Health at 20%.
| Income statement | Q1 2026 | Q1 2025 | Change |
|---|---|---|---|
| Revenue | $969M | $1.04B | −7.2% |
| Gross profit | $326M | $392M | −17% |
| Operating income | −$372M | $47M | to a loss |
| Net income | −$399M | −$6.4M | n/a |
| Diluted EPS | −$2.87 | −$0.05 | n/a |
| Product | Revenue | Share |
|---|---|---|
| Upper Respiratory | $178M | 22% |
| Skin Health | $162M | 20% |
| Healthy Lifestyle | $158M | 20% |
| Pain And Sleep | $125M | 16% |
| Digestive Health | $116M | 14% |
| Womens Health | $65M | 8.1% |
Business Segments
Revenue split by product segment, from SEC XBRL filings.
Latest period: Q2 2026Total $803.1M (+7.0%)
Womens Health grew +3.3% year on yearPain And Sleep -13% year on year
Segment Latestquarter on quarteryear on year
- Upper Respiratory$178.4M$178.4MQoQ -9.6%year on year -1.6%-9.6%-1.6%
- Skin Health$161.8M$161.8MQoQ +6.5%year on year -5.0%+6.5%-5.0%
- Healthy Lifestyle$157.8M$157.8MQoQ +11%year on year +2.0%+11%+2.0%
- Pain And Sleep$124.6M$124.6MQoQ +17%year on year -13%+17%-13%
- Digestive Health$115.7M$115.7MQoQ +20%year on year -3.4%+20%-3.4%
- Womens Health$64.8M$64.8MQoQ +18%year on year +3.3%+18%+3.3%
- Nutrition--QoQ -year on year ---
- Oral Selfcare--QoQ -year on year ---
- Pain And Sleep Aids--QoQ -year on year ---
- Product And Service Other--QoQ -year on year ---
- Skin Care--QoQ -year on year ---
- Vitamins Minerals and Supplements--QoQ -year on year ---
Drug Manufacturers - Specialty & Generic
Ranks #28 of 28 by Smart Score